Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.
Amit Vasanji, PhD, and Brett A. Hoover
Advertisement
Articles by Amit Vasanji, PhD, and Brett A. Hoover
Advertisement
Latest Updated Articles
Five Critical Qualities for Identifying a Partner to Globally Scale Ophthalmology Clinical TrialsPublished: March 22nd 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
3
Overcoming Recruitment and Retention Barriers in Alzheimer’s and Dementia Studies
4
AI in Action: Breaking Down Clinical Trial Bottlenecks
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
